Clinical Trial Update: Adjuvant Avelumab in Merkel Cell Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjuvant avelumab for Merkel cell carcinoma is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma

Drugs mentioned

• BAVENCIO (AVELUMAB)

Snippet

Sponsor: University of Washington | Conditions: Stage III Merkel Cell Carcinoma AJCC v8, Stage IIIB Merkel Cell Carcinoma AJCC v8 | Phase 3 | Status: ACTIVE_NOT_RECRUITING